Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of $1.15, $0.45 better than the analyst estimate of $0.70. Revenue for the quarter came in at $180.6 million versus the consensus estimate of $174.63 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.